Curon Biopharma

About:

Curon Biopharma is a Healthcare company.

Website: http://www.curonbiopharma.com/

Top Investors: Boyu Capital, 6 Dimensions Capital, Temasek Holdings

Description:

Curon Biopharma is a developer of drugs intended designed for immuno-oncology therapies. The company's drugs consist of multiple class-leading cancer immunotherapeutic agents in the world that could address the shortcomings of current cancer treatment paradigm, enabling a physician to provide advanced cancer immunotherapies to their patients.

Total Funding Amount:

$150M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2018-01-01

Founders:

Paul Song

Number of Employees:

11-50

Last Funding Date:

2018-07-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai